Azitma is indicated for treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed fellow:
acute bacterial sinusitis
acute bacterial otitis media
Pharyngitis, tonsillitis
acute exacerbation of chronic bronchitis
mild to moderate severe community acquired pneumonia
skin and soft tissue infections
uncomplicated chlamydia trachomatis urethritis and cervivitis.
Following information see from leaflet inside the pack:
Mechanism of action, Pharmacokinetics, Administration, Dosing consideration in special populations, contraindications, warinings and precautions, adverse ractions, drug interations, use in special population, overdosage.
